|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0790 HKD | +1.28% |
|
+9.72% | -3.66% |
| 06-30 | Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 06-23 | Extrawell Pharmaceutical Expects Swing to Loss in Fiscal 2026 | MT |
| Market Cap | 204M 26.03M 22.75M 21.03M 19.43M 36.58M 2.5B 37.25M 251M 98.38M 1.22B 97.76M 95.6M 4.22B | P/E 2024 |
-0.44x | P/E 2025 | 0.61x |
|---|---|---|---|---|---|
| Enterprise Value | -650M -82.92M -72.46M -66.99M -61.89M -117M -7.96B -119M -799M -313M -3.9B -311M -305M -13.43B | EV / Sales 2024 |
1.64x | EV / Sales 2025 | -13.5x |
| Free-Float |
65.45% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.28% | ||
| 1 week | +9.72% | ||
| Current month | +23.44% | ||
| 1 month | +12.86% | ||
| 3 months | -1.25% | ||
| 6 months | -18.56% | ||
| Current year | -3.66% |
| 1 week | 0.07 | 0.08 | |
| 1 month | 0.05 | 0.08 | |
| Current year | 0.05 | 0.12 | |
| 1 year | 0.05 | 0.15 | |
| 3 years | 0.03 | 0.15 | |
| 5 years | 0.03 | 0.2 | |
| 10 years | 0.03 | 0.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Guo
CEO | Chief Executive Officer | 45 | 2025-12-29 |
Hong Wu
DFI | Director of Finance/CFO | 54 | - |
Yong Cheng
PRN | Corporate Officer/Principal | 63 | 2019-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Yi Lou
BRD | Director/Board Member | 68 | 2008-10-05 |
Sau Kuen Wong
BRD | Director/Board Member | 63 | 2008-09-30 |
Yi Xie
CHM | Chairman | 63 | 2014-11-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-07-08 | Other | Director | 139,700,000 | 5.8452% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.28% | +9.72% | -5.95% | +49.06% | 28.86M | ||
| -2.48% | -6.72% | +44.19% | +156.43% | 1,028B | ||
| -1.52% | -5.01% | +61.87% | +58.79% | 611B | ||
| -1.30% | -3.88% | +27.81% | +79.97% | 432B | ||
| -0.09% | -2.54% | +28.00% | +21.70% | 323B | ||
| -0.62% | -3.21% | +26.86% | +43.50% | 277B | ||
| +0.19% | -12.91% | +18.16% | +21.59% | 257B | ||
| +0.80% | -0.19% | -25.53% | -39.82% | 217B | ||
| -1.44% | -3.49% | +19.60% | +56.20% | 192B | ||
| -1.04% | -4.63% | +16.01% | +68.47% | 161B | ||
| Average | -0.34% | -3.57% | +21.10% | +51.59% | 349.84B | |
| Weighted average by Cap. | -0.43% | -5.52% | +33.51% | +76.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 59.1M 7.54M 6.59M 6.09M 5.63M 10.6M 724M 10.79M 72.64M 28.5M 355M 28.32M 27.7M 1.22B | 55.43M 7.07M 6.18M 5.71M 5.28M 9.94M 679M 10.12M 68.13M 26.73M 333M 26.56M 25.98M 1.15B |
| Net income | -163M -20.79M -18.17M -16.8M -15.52M -29.22M -2B -29.75M -200M -78.58M -978M -78.09M -76.37M -3.37B | 223M 28.41M 24.82M 22.95M 21.2M 39.93M 2.73B 40.65M 274M 107M 1.34B 107M 104M 4.6B |
| Net Debt | 25.4M 3.24M 2.83M 2.62M 2.42M 4.55M 311M 4.64M 31.22M 12.25M 152M 12.17M 11.9M 525M | -854M -109M -95.21M -88.01M -81.32M -153M -10.46B -156M -1.05B -412M -5.12B -409M -400M -17.64B |
Employees
158
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | HK$0.0790 | +1.28% | 370,000 |
| 26-07-14 | HK$0.0780 | -4.88% | 2,150,000 |
| 26-07-13 | HK$0.0820 | +17.14% | 11,080,000 |
| 26-07-10 | HK$0.0700 | -2.78% | 1,570,000 |
| 26-07-09 | HK$0.0720 | 0.00% | 3,570,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 858 Stock
Select your edition
All financial news and data tailored to specific country editions
















